Sanara MedTech Inc. — Director's Dealing 2017

Apr 6, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: WOUND MANAGEMENT TECHNOLOGIES, INC. (WNDM)
CIK: 0000714256
Period of Report: 2014-12-19

Reporting Person: Siedhoff John Christopher (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	6250000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series D Preferred Stock	$		Common Stock (750000)		Direct

Footnotes

F1: Each share of Series D Preferred Stock has the right to convert, on a 1,000-for-1 basis, into shares of the issuer's common stock, but only at such time as the issuer's charter has been amended to increase the authorized number of shares of common stock from 100,000,000 to 250,000,000.